Blood diagnostic testing developer Sight Diagnostics announced this week that it raised $71 million in a Series D financing round. Koch Disruptive Technologies, Longliv Ventures and OurCrowd participated in the round, bringing Sight Diagnostics’ total funding to more than $124 million, according to a news release. Tel Aviv, Israel-based Sight Diagnostics said the funding will […]
Sight Diagnostics
FDA clearance positions Sight Diagnostics to deliver on two-drop blood testing promise
Today’s news that Sight Diagnostics secured 510(k) clearance for its Olo analyzer certainly will reduce the flow of future patient tears and fears as the system requires just two drops of blood to conduct a range of tests. However, the clearance — which confirms the Olo works just as well as gold-standard lab-grade systems in […]